The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...

Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone ...

Zydus Lifesciences announced that it has launch ANVIMO (Letermovir), a new and innovative treatment for the prevention of Cytomegalovirus (CMV) infection in hematopoietic stem cell transplant (HSCT) ...

Seres Therapeutics (MCRB) announced that it has received constructive feedback from a Type B Breakthrough Therapy designation engagement with ...

Seres has submitted clarification questions to FDA and expects a response in the coming weeks, which will inform the proposed ...

A timely medical intervention in the form of a bone marrow transplant, medically known as hematopoietic stem cell ...

On World Rare Disease Day, Apollo Hospital Navi Mumbai highlighted a rare medical success story, treating a four-year-old ...

Fungal infection, also known as a mycosis, refers to the invasion of a host's tissue by specific types of fungi. Mycoses often start in the lungs following inhalation of fungal spores or on the ...

It's made up of a complicated network of cells and organs. It protects the body from infection, cancer, and other conditions. Lymph nodes are part of the immune system. They send out lymphocytes.

AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of ...